Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours
- 28 February 2005
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 200 (2) , 173-178
- https://doi.org/10.1016/j.jamcollsurg.2004.10.010
Abstract
Background Although trauma patients often suffer direct lung damage, an equally destructive mechanism of lung injury involves postinjury systemic inflammation. We postulate that secretory phospholipase A 2 (sPLA 2) release induced by trauma relates to systemic inflammation that compromises both lung function and clinical status after injury. The objectives of this study were: to relate Injury Severity Score to postinjury sPLA 2; to determine whether circulating sPLA 2 relates to pulmonary oxygenation and compliance; and to determine whether early or persistent increases in sPLA 2 are associated with abnormal chest x-ray at 72 hours after injury. Study design The prospective cohort study comprised 54 consecutive intensive care admissions in patients with traumatic injury admitted over a 6-month period from November 1, 1996, to May 1, 1997. Results Postinjury peak sPLA 2 values were associated with increased ISS (r = 0.49, r 2 = 0.24, p < 0.001). Patients with elevated sPLA 2 had poor oxygenation compared with those with normal sPLA 2 levels (Pa0 2/Fi0 2 ratio 164 ± 16 versus 260 ± 26 mmHg [mean ± SEM], p < 0.01) and also required additional PEEP (5.5 ± 0.9 versus 2.5 ± 0.4 cm H 2O, p = 0.01). Secretory PLA 2 levels in patients with abnormal chest x-ray 72 hours after injury were higher (1.08 ± 0.2 versus 0.34 ± 0.1 activity units, p < 0.001) than levels seen in patients with normal x-rays. Conclusions Increasing injury magnitude is associated with elevated sPLA 2 levels, and increased sPLA 2 is related to postinjury hypoxemia and clinical status.Keywords
This publication has 14 references indexed in Scilit:
- Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureCritical Care Medicine, 2003
- Effect of surfactant on pulmonary expression of type IIA PLA2 in an animal model of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Incidence and Mortality after Acute Respiratory Failure and Acute Respiratory Distress Syndrome in Sweden, Denmark, and IcelandAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.Journal of Clinical Investigation, 1998
- Clinical risks for development of the acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1995
- Serum Phospholipase A2 in Patients with Multiple InjuriesPublished by Wolters Kluwer Health ,1990
- Sequential Patterns of Eicosanoid, Platelet, and Neutrophil Interactions in the Evolution of the Fulminant Post-traumatic Adult Respiratory Distress SyndromeAnnals of Surgery, 1989
- Serum phospholipase A2 activity in acute pancreatitis: An early guide to severityBritish Journal of Surgery, 1989
- Pathogenesis of hypotension in septic shockCritical Care Medicine, 1988